Bioreactors and Fermenters Global Market Report 2024

The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $3.6 billion in 2023 to $ 4.12 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The expansion observed in the historical period can be attributed to several factors, including the rising demand for biopharmaceuticals, increased investments in research and development endeavors, the expansion of the biotechnology industry, a heightened emphasis on sustainable practices, and the growing demand for personalized medicine solutions.

The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to $7.06 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The anticipated growth in the forecast period can be attributed to various factors, including the emergence of new biopharmaceutical companies, heightened demand for vaccine production, a growing focus on precision medicine, expansion in biotechnology research initiatives, and increased investments in healthcare infrastructure. Major trends expected in this period encompass the wider adoption of next-generation bioreactor technologies, the expansion of bioproduction capacities particularly in emerging markets, the emergence of integrated continuous bioprocessing methods, a heightened emphasis on sustainability and environmentally friendly bioprocessing practices, and the integration of artificial intelligence and machine learning technologies into bioprocessing operations.

The bioreactors and fermenters market is set to experience significant growth, driven by increasing investments in biotechnology ventures. Biotechnology investment involves the allocation of financial resources into biotechnology companies and projects, fueled by rising demand for innovative healthcare solutions and advancements in genetic engineering. These investments play a crucial role in advancing biotechnological processes and accelerating biopharmaceutical production, supporting research and development efforts aimed at enhancing bioreactor and fermentor technologies. Furthermore, they facilitate the scale-up and commercialization of these technologies, promoting their adoption in industrial biomanufacturing settings. According to the UK Biotech Financing Report published by the BioIndustry Association (BIA) in January 2022, the UK biotech sector witnessed a substantial increase in financial backing in 2021, with total funds raised reaching $5.77 billion, marking a significant rise compared to the previous year. This surge in biotechnology investment is a key driver behind the growth of the bioreactors and fermenters market.

Leading companies in the bioreactors and fermenters market are leveraging innovation to enhance profitability by developing advanced technological solutions. Next-Gen bioreactor remote monitoring and control software represent one such innovation, providing specialized computer programs or systems designed to oversee and manage bioreactors and fermenters remotely. For example, The Cultivated B GmbH introduced AUXO V software in November 2023, offering real-time monitoring and personalized interfaces accessible remotely via phone and web-based platforms. This next-generation software enables direct or remote control of bioprocesses, ensuring 24/7 monitoring for prompt intervention and automated processes to optimize workforce allocation.

In November 2021, Donaldson Company Inc. strengthened its position in the bioreactors and fermenters market through the acquisition of Solaris Biotechnology Srl. This strategic acquisition allowed Donaldson Company Inc. to expand its product portfolio and enhance its presence in the life sciences market. Solaris Biotechnology Srl, based in Italy, specializes in the design and production of benchtop, pilot, and industrial fermenters and bioreactors, complementing Donaldson's expertise in filtration solutions.

Major companies operating in the bioreactors and fermenters market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, GE Healthcare, Sartorius AG, Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin SAS, Parr Instrument Company, Bionet Inc., PBS Biotech, Bioengineering AG, Finesse Solutions, Ollital Technology, Shanghai Bailun Biological Technology, Zhengzhou Laboao Instrument Equipment, Scigenics Pvt. Ltd., Infors AG, Synthecon Inc., Cellexus Ltd.

North America was the largest region in the bioreactors and fermenters market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors and fermenters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioreactors and fermenters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bioreactors and fermenters are specialized systems crucial in biotechnology and industrial operations, facilitating the controlled cultivation and growth of microorganisms, cells, or tissues. They provide a precisely regulated environment vital for the development and refinement of bioprocesses aimed at producing bio-based products. A bioreactor serves as a vessel tailored for the cultivation of microorganisms or cells under controlled conditions for various biotechnological applications. On the other hand, a fermentor is a subtype of bioreactor specifically engineered for microbial fermentation processes, primarily utilized in the production of enzymes, antibiotics, and biofuels.

The primary types of bioreactors and fermenters are single-use and multiple-use variants. Single-use bioreactors, also referred to as disposable bioreactors or reactors, are utilized in the biotechnology and pharmaceutical sectors for cultivating cells or microorganisms. Employing processes such as fed-batch, continuous, and batch operations, these bioreactors find application across a spectrum of end users including biopharmaceutical firms, beverage manufacturers, contract research organizations (CROs), as well as academic and research institutions.

The bioreactors and fermenters market research report is one of a series of new reports that provides bioreactors and fermenters market statistics, including bioreactors and fermenters industry global market size, regional shares, competitors with a bioreactors and fermenters market share, detailed bioreactors and fermenters market segments, market trends and opportunities, and any further data you may need to thrive in the bioreactors and fermenters industry. This bioreactors and fermenters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioreactors and fermenters market consists of sales of stirred-tank bioreactors, batch bioreactors, stirred-tank bioreactors, photobioreactors, and anaerobic fermenters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.